| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0304-3940(99)00148-2 |
| P8608 | Fatcat ID | release_p6zegs7qyzg4jos55m3p52ptmy |
| P698 | PubMed publication ID | 10213158 |
| P2093 | author name string | L Gong | |
| R J Wyatt | |||
| I Baker | |||
| J M Masserano | |||
| P2860 | cites work | Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo | Q28306009 |
| Activation of Endogenous Antioxidant Defenses in Neuronal Cells Prevents Free Radical‐Mediated Damage | Q41029391 | ||
| Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats | Q41033079 | ||
| Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats | Q41049485 | ||
| Nitric oxide induces cell death in a catecholaminergic cell line derived from the central nervous system | Q41057962 | ||
| Selective role of glutathione in protecting human neuronal cells from dopamine-induced apoptosis | Q41200357 | ||
| Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo | Q41428400 | ||
| Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice | Q41572385 | ||
| Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. | Q48196753 | ||
| Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system | Q48459449 | ||
| Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. | Q67228281 | ||
| Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinsonʼs disease | Q71788854 | ||
| BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine | Q72030743 | ||
| P433 | issue | 2-3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 153-156 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Neuroscience Letters | Q7002625 |
| P1476 | title | Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death | |
| P478 | volume | 263 |
| Q48363538 | Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levels. |
| Q37914155 | Astrocytes and Microglia: Responses to Neuropathological Conditions |
| Q44535402 | Beta-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells: influence of the antioxidant melatonin |
| Q40683212 | Bimodal upregulation of glial cell line-derived neurotrophic factor (GDNF) in the neonatal rat brain following ischemic/hypoxic injury |
| Q36957642 | Bu Shen Tiao Chong recipe restores diminished ovary reserve through the BDNF pathway |
| Q48432417 | Chronic lithium treatment has antioxidant properties but does not prevent oxidative damage induced by chronic variate stress |
| Q48684233 | Effects of brain-derived neurotrophic factor (BDNF) on compression-induced spinal cord injury: BDNF attenuates down-regulation of superoxide dismutase expression and promotes up-regulation of myelin basic protein expression |
| Q39634067 | Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestoration |
| Q42286702 | Ethanol Influences on Bax Translocation, Mitochondrial Membrane Potential, and Reactive Oxygen Species Generation Are Modulated by Vitamin E and Brain‐Derived Neurotrophic Factor |
| Q40774885 | Expression of glial cell line-derived neurotrophic factor (GDNF) in the developing human fetal brain |
| Q40204577 | GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease |
| Q46514011 | Glia cell number modulates sensitivity to MPTP in mice |
| Q40821071 | Glial cell line-derived neurotrophic factor promotes sleep in rats and rabbits |
| Q32034638 | Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction |
| Q40653555 | Immunosuppressive (FK506) and non-immunosuppressive (GPI1046) immunophilin ligands activate neurotrophic factors in the mouse brain |
| Q48589275 | Inter-relation between brain-derived neurotrophic factor and antioxidant enzymes in bipolar disorder |
| Q33908238 | Metabolism and functions of glutathione in brain. |
| Q48925777 | Neuroprotective effects of dipeptide analogue of brain-derived neurotrophic factor GSB-106 in in vitro experiments |
| Q37393553 | Neurotrophic support and oxidative stress: converging effects in the normal and diseased nervous system |
| Q39139656 | Oral administration of docosahexaenoic acid activates the GDNF-MAPK-CERB pathway in hippocampus of natural aged rat. |
| Q42514742 | Striatal dopamine output is compromised within +/− BDNF mice |
| Q32134268 | Superoxide dismutase activity in organotypic midbrain-striatum co-cultures is associated with resistance of dopaminergic neurons to excitotoxicity. |
Search more.